Lipocine Inc. Files Q1 2025 10-Q Report
Ticker: LPCN · Form: 10-Q · Filed: May 8, 2025 · CIK: 1535955
| Field | Detail |
|---|---|
| Company | Lipocine Inc. (LPCN) |
| Form Type | 10-Q |
| Filed Date | May 8, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-report, pharmaceutical
TL;DR
Lipocine Inc. Q1 2025 10-Q filed. Check financials.
AI Summary
Lipocine Inc. filed its 10-Q for the period ending March 31, 2025. The company reported financial results and provided updates on its business operations. Specific financial figures and operational details are available within the full filing.
Why It Matters
This filing provides investors with the latest financial performance and operational status of Lipocine Inc., crucial for understanding the company's trajectory and investment potential.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Lipocine Inc. faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2025-03-31 — Period End Date (The end of the fiscal quarter reported)
- 2025-05-08 — Filing Date (The date the report was submitted to the SEC)
Key Players & Entities
- Lipocine Inc. (company) — Filer of the 10-Q report
- 0001641172-25-009180 (accession_number) — Unique identifier for the filing
- 20250331 (date) — End of the reporting period
- 20250508 (date) — Filing date
- SALT LAKE CITY (location) — City where Lipocine Inc. is located
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is the quarter ended March 31, 2025.
When was this 10-Q filed with the SEC?
This 10-Q was filed on May 8, 2025.
What is the company's name and Central Index Key (CIK)?
The company's name is Lipocine Inc., and its CIK is 0001535955.
Where is Lipocine Inc. located?
Lipocine Inc. is located at 675 Arapeen Drive, Suite 202, Salt Lake City, UT 84108.
What is the Standard Industrial Classification (SIC) code for Lipocine Inc.?
The SIC code for Lipocine Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 8, 2025 regarding Lipocine Inc. (LPCN).